Matches in Nanopublications for { ?s ?p "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP384725.RAQw4SSeLHw_y_1n-tJJcbvD0DPrOzenDFsREZP_B3aQk130_assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384725.RAQw4SSeLHw_y_1n-tJJcbvD0DPrOzenDFsREZP_B3aQk130_provenance.
- NP419298.RAT7jjeQMldfFfX0zYUdOd33YksyJoGfGUOSmyLrnq-Nc130_assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419298.RAT7jjeQMldfFfX0zYUdOd33YksyJoGfGUOSmyLrnq-Nc130_provenance.
- NP617347.RAZbyCfC5jtBz1P0xo9RA5I_fRIiEf-0bRpt9ELfwETjo130_assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617347.RAZbyCfC5jtBz1P0xo9RA5I_fRIiEf-0bRpt9ELfwETjo130_provenance.
- assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1126278.RAkuWweAtkntbNrmY2MFetqQfca2QsNF1_18aGmopoP-M130_assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126278.RAkuWweAtkntbNrmY2MFetqQfca2QsNF1_18aGmopoP-M130_provenance.
- NP1126280.RAjAC9UkDrVKdIXERN5SStwJUZvPqJTeHscAYyD3sd1i4130_assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126280.RAjAC9UkDrVKdIXERN5SStwJUZvPqJTeHscAYyD3sd1i4130_provenance.
- NP617574.RAz-Km4jI3DfD6RCwp-kc5ilpLXRQLjK4xTs4oZuZL_DA130_assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617574.RAz-Km4jI3DfD6RCwp-kc5ilpLXRQLjK4xTs4oZuZL_DA130_provenance.
- NP1126272.RAEFPuRslLICFClM_t_7FeDNjXAhsEqwl0bjpVTYwd5lc130_assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126272.RAEFPuRslLICFClM_t_7FeDNjXAhsEqwl0bjpVTYwd5lc130_provenance.
- NP1126276.RA6BQGiRHbdDg62whREmaVYFEKTjo5R6UY-_NJNfYt8x8130_assertion description "[In a transcriptomic survey aimed at identifying molecular factors associated with lymph node involvement of ductal breast cancer, we found that luminal differentiation, assessed by the expression of estrogen receptor (ER) and/or progesterone receptor (PR) and GATA3, was only infrequently lost in node-positive primary tumors and in matched lymph node metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126276.RA6BQGiRHbdDg62whREmaVYFEKTjo5R6UY-_NJNfYt8x8130_provenance.